SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-068460
Filing Date
2018-11-14
Accepted
2018-11-14 16:23:13
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-37060_110q.htm 10-Q 1175743
2 EX-10.1 a18-37060_1ex10d1.htm EX-10.1 207181
3 EX-10.4 a18-37060_1ex10d4.htm EX-10.4 98487
4 EX-31.1 a18-37060_1ex31d1.htm EX-31.1 11590
5 EX-31.2 a18-37060_1ex31d2.htm EX-31.2 12202
6 EX-32.1 a18-37060_1ex32d1.htm EX-32.1 7889
  Complete submission text file 0001104659-18-068460.txt   4144301

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ettx-20180930.xml EX-101.INS 611768
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ettx-20180930.xsd EX-101.SCH 34298
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ettx-20180930_cal.xml EX-101.CAL 34562
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ettx-20180930_lab.xml EX-101.LAB 305803
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ettx-20180930_pre.xml EX-101.PRE 227985
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ettx-20180930_def.xml EX-101.DEF 126666
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38670 | Film No.: 181184228
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1